| Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis (NCT05322070) | Alimera Sciences | 2022-06-06 |
| Ozurdex Monotherapy Trial (NCT05101928) | Ottawa Hospital Research Institute | 2021-11-30 |
| Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert (NCT05070728) | EyePoint Pharmaceuticals, Inc. | 2021-10-13 |
| Safety &Efficacy of CF101 to Subjects With Uveitis (NCT01905124) | Can-Fite BioPharma | 2019-01-01 |
| Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer) (NCT03656692) | Mallinckrodt | 2018-10-05 |
| MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301 (NCT02952001) | Clearside Biomedical, Inc. | 2017-12-13 |
| Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant (NCT03145025) | Bausch & Lomb Incorporated | 2017-07-14 |
| Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis (NCT03097315) | Clearside Biomedical, Inc. | 2017-04-04 |
| Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis (NCT03066869) | Ocular Immunology and Uveitis Foundation | 2017-03-22 |
| Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis (NCT02595398) | Clearside Biomedical, Inc. | 2015-11-17 |
| Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis (NCT02255032) | Clearside Biomedical, Inc. | 2014-10-01 |
| Safety and Preliminary Efficacy Study of V404 PDS in Uveitis (NCT02125266) | Forsight Vision4 | 2014-04-01 |
| Study of the Effectiveness of Ozurdex for the Control of Uveitis (NCT02049476) | Johns Hopkins University | 2014-01-01 |
| High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients (NCT03598452) | Aier School of Ophthalmology, Central South University | 2014-01-01 |
| A Long-Term Safety Study of OZURDEX® in Clinical Practice (NCT01539577) | Allergan | 2012-03-01 |
| A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis (NCT00404612) | Lux Biosciences, Inc. | 2007-01-01 |
| A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis (NCT00404742) | Lux Biosciences, Inc. | 2007-01-01 |
| Prophylactic Anecortave Acetate in Patients With a Retisert Implant (NCT00570479) | Texas Retina Associates | 2006-09-01 |